Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Open-Label, Parallel Group, Multi-Center, Prospective Phase 4 Study Comparing the Efficacy of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

NCT05496296 is registered in ClinicalTrials.gov with ULURU Inc. as lead sponsor.

NCT NCT05496296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05496296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Open-Label, Parallel Group, Multi-Center, Prospective Phase 4 Study Comparing the Efficacy of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
Lead sponsor
ULURU Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2023
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

pressure ulcer, stage iv, pressure ulcers stage ii, pressure ulcers stage iii